☰

Todd A. Aguilera, Ph.D. - Publications

Affiliations: 
2009 Biomedical Sciences University of California, San Diego, La Jolla, CA 
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sanford NN, Folkert MR, Aguilera TA, Beg MS, Kazmi SA, Sanjeevaiah A, Zeh HJ, Farkas L. Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016. American Journal of Clinical Oncology. PMID 32976176 DOI: 10.1200/Jco.2020.38.15_Suppl.E16000  0.31
2020 Ganguly D, Chandra R, Karalis J, Teke M, Aguilera T, Maddipati R, Wachsmann MB, Ghersi D, Siravegna G, Zeh HJ, Brekken R, Ting DT, Ligorio M. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment. Cancers. 12. PMID 32957515 DOI: 10.3390/Cancers12092652  0.36
2020 Goksu SY, Ozer M, Kazmi SMA, Sanford NN, Aguilera TA, Ahn C, Hsiehchen D, Sanjeevaiah A, Khosama L, Bleeker J, Atiq M, Beg MS. Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor. Cancers. 12. PMID 32899271 DOI: 10.3390/Cancers12092501  0.332
2020 Sanford NN, Aguilera TA, Beg MS, Sanjeevaiah A, Hong TS, Wo JY, Folkert MR. Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015. American Journal of Clinical Oncology. PMID 32235162 DOI: 10.1097/Coc.0000000000000674  0.31
2020 Aguilera TA, Elghonaimy E, Shehade H, Rafat M, Castellini L, Jiang D, Kariolis M, Koong A, Le QT, Ellies LG, Rankin EB, Graves EE, Giaccia AJ. Induced tumor heterogeneity reveals factors informing radiation and immunotherapy combinations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32098769 DOI: 10.1158/1078-0432.Ccr-19-4220  0.319
2020 Goksu SY, Ozer M, Kazmi SMA, Sanford NN, Aguilera TA, Hsieh D, Sanjeevaiah A, Verma U, Khosama L, Maxwell MC, Bleeker J, Atiq M, Beg MS. Distinct clinical characteristics in young-onset pancreatic neuroendocrine tumor: A propensity-adjusted analysis. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E16710  0.323
2019 Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, Liang R, Agarwal S, Colevas AD, Korman A, Allen CT, et al. Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. The Journal of Clinical Investigation. PMID 31710313 DOI: 10.1172/Jci129025  0.354
2018 Rafat M, Aguilera TA, Vilalta M, Bronsart LL, Soto LA, von Eyben R, Golla MA, Ahrari Y, Melemenidis S, Afghahi A, Jenkins MJ, Kurian AW, Horst K, Giaccia AJ, Graves EE. Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence Following Radiation Therapy in Immunosuppressed Patients. Cancer Research. PMID 29880480 DOI: 10.1158/0008-5472.Can-17-3623  0.367
2018 Nambiar DK, Aguilera TA, Bloomstein JD, Jiang D, Cao H, Koong A, Le QT. Abstract 4068: Galectin-1 intensifies immunosuppression in head and neck cancer by boosting myeloid-derived suppressive cell (MDSC) expansion Cancer Research. 78: 4068-4068. DOI: 10.1158/1538-7445.Am2018-4068  0.383
2018 Nambiar D, Aguilera TA, Bloomstein JD, Cao H, Koong AC, Le QT. Galectin-1 Orchestrates Immune Evasion in Head and Neck Cancer by Suppressing T Cell Recruitment to Tumors International Journal of Radiation Oncology Biology Physics. 100: 1314. DOI: 10.1016/J.Ijrobp.2017.12.035  0.323
2017 Aguilera TA, Giaccia AJ. Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion- A New Role for the AXL Receptor Tyrosine Kinase. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28289089 DOI: 10.1158/1078-0432.Ccr-17-0189  0.32
2017 Nambiar DK, Aguilera T, Bloomstein JD, Cao H, Koong A, Le QT. Abstract LB-180: Targeting galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-180  0.376
2016 Wu J, Aguilera T, Shultz D, Gudur M, Rubin DL, Loo BW, Diehn M, Li R. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 151829. PMID 27046074 DOI: 10.1148/Radiol.2016151829  0.364
2016 Rafat M, Vilalta M, Aguilera TA, Giaccia AJ, Graves EE. Abstract 5124: Tumor and immune cell infiltration are enhanced by irradiation of normal tissues in immunocompromised mice Cancer Research. 76: 5124-5124. DOI: 10.1158/1538-7445.Am2016-5124  0.409
2016 Aguilera TA, Rafat MR, Castellini L, Kariolis MS, vonEbyen R, Graves EE, Giaccia AJ. Abstract 4988: Reprogramming the immunologic microenvironment through radiation and Axl targeting Cancer Research. 76: 4988-4988. DOI: 10.1158/1538-7445.Am2016-4988  0.367
2015 Aguilera T, Rafat M, Kariolis M, von Eyben R, Graves E, Giaccia A. Tumor immunologic heterogeneity influences response to radiation and combination immunotherapy Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P345  0.346
2013 Aguilera T, Daniel G, Shultz D, Trakul N, Maxim P, Rubin D, Loo B, Diehn M. Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S546. DOI: 10.1016/J.Ijrobp.2013.06.1444  0.314
2012 Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, Jiang T, Baird SM, Tsimikas S, Tsien RY, Nguyen QT. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integrative Biology : Quantitative Biosciences From Nano to Macro. 4: 595-605. PMID 22534729 DOI: 10.1039/C2Ib00161F  0.736
2011 Shu X, Lev-Ram V, Olson ES, Aguilera TA, Jiang T, Whitney M, Crisp JL, Steinbach P, Deerinck T, Ellisman MH, Ellies LG, Nguyen QT, Tsien RY. Spiers Memorial Lecture. Breeding and building molecular spies. Faraday Discussions. 149: 9; discussion 63-77. PMID 21413170 DOI: 10.1039/C0Fd90021D  0.719
2011 Olson ES, Tsien RY, Savariar EN, Crisp JL, Jiang T, Aguilera TA, Whitney MA, Steinbach P, Ellies LG, Nguyen QT. Abstract IA1: Building molecules to guide anticancer therapy Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-Ia1  0.726
2010 Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjugate Chemistry. 21: 1811-9. PMID 20873712 DOI: 10.1021/Bc1001328  0.7
2010 Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, Tsien RY. Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides. The Journal of Biological Chemistry. 285: 22532-41. PMID 20460372 DOI: 10.1074/Jbc.M110.138297  0.739
2010 Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, Tsien RY. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proceedings of the National Academy of Sciences of the United States of America. 107: 4317-22. PMID 20160097 DOI: 10.1073/Pnas.0910261107  0.622
2010 Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proceedings of the National Academy of Sciences of the United States of America. 107: 4311-6. PMID 20160077 DOI: 10.1073/Pnas.0910283107  0.619
2009 Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Gross LA, Tsien RY. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integrative Biology : Quantitative Biosciences From Nano to Macro. 1: 382-93. PMID 20023745 DOI: 10.1039/B904890A  0.592
2009 Aguilera TA, Olson ES, Timmers MM, Jiang T, Tsien RY. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. Integrative Biology : Quantitative Biosciences From Nano to Macro. 1: 371-81. PMID 20023744 DOI: 10.1039/B904878B  0.568
2009 Lin MZ, McKeown MR, Ng HL, Aguilera TA, Shaner NC, Campbell RE, Adams SR, Gross LA, Ma W, Alber T, Tsien RY. Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chemistry & Biology. 16: 1169-79. PMID 19942140 DOI: 10.1016/J.Chembiol.2009.10.009  0.736
2009 Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science (New York, N.Y.). 324: 804-7. PMID 19423828 DOI: 10.1126/Science.1168683  0.712
2008 Vorasubin N, Nguyen QT, Olson E, Aguilera TA, Jiang T, Tsien RY. Cell Penetrating Peptide Uptake by Human Tissue. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 139: P35. PMID 29400176 DOI: 10.1016/J.Otohns.2008.05.116  0.558
2008 Nguyen QT, Olson E, Aguilera TA, Vorasubin N, Jiang T, Tsien RY. R419 – Surgery with Molecular Fluorescence Imaging Guidance Otolaryngology–Head and Neck Surgery. 139: P183-P184. DOI: 10.1016/J.Otohns.2008.05.573  0.622
Show low-probability matches.